Event Highlight: Bridging Science, Advocacy, and Practice – A Unified Approach to Combating AMR
- Rodrigo Scotini
- 4 days ago
- 2 min read
📍 Jernesalen, Statens Serum Institut Campus, Copenhagen & Online – March 24, 2025
📅 Hosted by the Infectious Disease Alliance (IDA) and Statens Serum Institut (SSI)
Antimicrobial resistance (AMR) poses one of the most serious threats to global health today—cutting across human, animal, and environmental health. In response, the Infectious Disease Alliance (IDA), in collaboration with the Statens Serum Institut (SSI), convened global leaders for a hybrid event exploring a One Health approach to fighting AMR through science, advocacy, and policy-driven action.
Held on March 24, 2025, this pivotal event brought together over 50 experts and attendees from across Europe, Africa, the Americas, and Asia to share bold strategies and data-driven insights that will inform global and national AMR responses.
🔬 Science Meets Strategy
Keynote Highlights:
Dr. Kristian Møller outlined Denmark’s antibiotic surveillance in pig farming and the unintended rise in resistance following the zinc oxide ban—calling for data-sharing and more flexible policies.
Cóilín Nunan stressed that EU regulations on farm antibiotic use must go further by reducing group treatments and promoting improved animal welfare.
Dr. Dominique Monnet of ECDC revealed a 60% rise in carbapenem-resistant Klebsiella pneumoniae and emphasized the importance of genomic surveillance and national CRE action plans.
Dr. Chantal Morel urged reframing AMR economics to focus on “treatability” and contextualized investment in LMIC realities.
Dr. Danilo Lo-Fo-Wong presented the WHO Europe AMR Roadmap, highlighting interactive tools and people-centered approaches across 53 member states.
💡 From Resistance to Resilience
Speakers showcased breakthrough models and tools, including:
DANMAP (Denmark’s integrated AMR surveillance system) by Dr. Ute Wolff Sönksen, a model in transparency and outbreak control.
The iChip tool presented by Prof. Kim Lewis, facilitating culture of previously unculturable microbes, reigniting hopes for new antibiotic discovery.
The session emphasized innovative funding models—from milestone-based R&D financing to environmental accountability in pharmaceutical production. Notably, Dr. Andrea Caputo Svensson argued for “access without excess” and spotlighted public and nonprofit models for sustainable antibiotic access.
🔄 Interactive Dialogue
Participants raised critical issues including:
Zinc use in pig farming, where low-dose strategies may cut antibiotic use by up to 40%.
Sepsis in AMR plans, as highlighted by Dr. Lo-Fo-Wong in light of WHA’s global action on sepsis.
📣 A Unified Call to Action
The event concluded with a strong Call to Action, urging:
Governments to realign incentives and support milestone-based antibiotic development.
Healthcare and veterinary professionals to adopt stricter stewardship and diagnostics.
Researchers and civil society to amplify public awareness and global collaboration.
▶️ Watch the Full Recording
By bridging research, policy, and on-the-ground implementation, IDA is advancing a sustainable, cross-sectoral AMR agenda. As AMR continues to evolve, IDA remains committed to convening experts and translating knowledge into action.
🦠 Together, let’s build a world resilient to antimicrobial resistance.
Comentarios